E.W. Yemeli Tido et al. / Inorganica Chimica Acta 360 (2007) 3896–3902
3901
Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax:
(+44) 1223-336-033; or e-mail: deposit@ccdc.cam.ac.uk.
Supplementary data associated with this article can be
4.0
3.8
3.6
3.4
3.2
3.0
2.8
References
[1] C. Shipman Jr., S.H. Smith, J.C. Drach, D.L. Klayman, Antiviral
Res. 6 (1986) 197.
0
50 100 150 200 250 300
T/K
´
[2] S. Padhye, G.B. Kauffman, Coord. Chem. Rev. 63 (1985) 127.
[3] D.X. West, S.L. Dietrich, I. Thientanavanich, C.A. Brown, A.E.
Liberta, Transit. Met. Chem. 19 (1994) 195.
[4] J. Yuan, D.B. Lovejoy, D.R. Richardson, Blood 104 (2004) 1450.
[5] J. Shao, B. Zhou, B. Chu, Y. Yen, Curr. Cancer Drug Targets 6
(2006) 409.
Fig. 4. Temperature dependence of
(CH3C6H4SO3). The solid line corresponds to the fit using the parameters
described in the text.
vMT for [Fe(H2mthpy)Cl2]-
[6] A. Jordan, P. Reichard, Annu. Rev. Biochem. 67 (1998) 71.
[7] P. Nordlund, H. Eklund, J. Mol. Biol. 232 (1993) 123.
[8] J. Shao, B. Zhou, A.J. Di Bilio, L. Zhu, T. Wang, C. Qi, J. Shih, Y.
Yen, Mol. Cancer Ther. 5 (2006) 586.
[9] D.B. Lovejoy, D.R. Richardson, Blood 100 (2002) 666.
[10] J.L. Buss, F.M. Torti, S.V. Torti, Curr. Med. Chem. 10 (2003) 1021.
[11] J.L. Buss, B.T. Greene, J. Turner, F.M. Torti, S.V. Torti, Curr. Top.
Med. Chem. 4 (2004) 1623.
[12] D.R. Richardson, E.H. Tran, P. Ponka, Blood 86 (1995) 4295.
[13] M. Belicchi Ferrari, F. Bisceglie, E. Leporati, G. Pelosi, P. Tarasconi,
Bull. Chem. Soc. Jpn. 75 (2002) 781.
[14] M. Belicchi Ferrari, F. Bisceglie, G. Pelosi, P. Tarasconi, R. Albertini,
P.P. Dall’Aglio, S. Pinelli, A. Bergamo, G. Sava, J. Inorg. Biochem.
98 (2004) 301.
where, X = D/kT, D is the zero-field splitting parameter, g
´
is the Lande factor and the other symbols have their usual
meanings. Eq. (1) is the theoretical equation for the mag-
netic susceptibility resulting from the axial and rhombic
zero-field splitting for an S = 5/2 ion [35]. The best fit
has been obtained with the parameters D = 0.34(1) cmꢀ1
and g = 2.078(3) with a correlation coefficient of 0.98 and
a reduced v2 of 0.0015.
4. Conclusion
[15] V.M. Leovac, V.S. Jevtovic, L.S. Jovanovic, G.A. Bogdanovic, Rev.
J. Serb. Chem. Soc. 70 (2005) 393.
[16] M. Mohan, P.H. Madhuranath, A. Kumar, M. Kumar, N.K. Jha,
Inorg. Chem. 28 (1989) 96.
[17] N.S. Gupta, M. Mohan, N.K. Jha, W.E. Antholine, Inorg. Chim.
Acta 184 (1991) 13.
[18] V.S. Jevtovic, L.S. Jovanovic, V.M. Leovac, L.J. Bjelica, J. Serb.
Chem. Soc. 68 (2003) 929.
Dichloropyridoxal-4-methylthiosemicarbazone iron(III)
p-toluenesulfonate has been obtained by reacting iron(III)
p-toluenesulfonate hexahydrate with pyridoxal-4-methyl-
thiosemicarbazone hydrochloride followed by crystallisa-
tion at room temperature. The crystal structure revealed
a five-coordinate Fe(III) ion in an ONSCl2 environment
that is intermediate between trigonal bipyramidal and
square pyramidal. To the best of our knowledge this is
the first instance in which coordination of this set of donor
atoms to iron has been crystallographically identified. The
ligand is in its neutral zwitterionic form, i.e. it is deproto-
nated at the phenolic-O whereas it is protonated at the pyr-
idine-N and the hydrazinic-N, and coordinates to Fe(III)
by using its thione-S, phenolic-O, and azomethine-N.
The magnetic data are consistent with the behaviour
typical for a high spin Fe(III) ion subjected to zero-field
splitting. The D value of 0.34(1) cmꢀ1 that has been deter-
mined for the present five-coordinate Fe(III) compound
(s = 0.40) is of the same magnitude as the zero-field split-
ting parameter of 0.79 cmꢀ1 that has been reported for
chloro-(N-p-nitrobenzoylimido-meso-tetraphenylporphiri-
nato)iron(III) (s = 0.65).
[19] M. Belicchi Ferrari, G. Fava Gasparri, E. Leporati, C. Pelizzi, P.
Tarasconi, G. Tosi, J. Chem. Soc., Dalton Trans. (1986) 2455.
[20] Bruker, SMART, SAINTPLUS and XPREP Area Detector Control and
integration Software, Smart Apex Software Reference Manuals
Bruker Analytical X-ray instruments Inc., Madison, Wisconsin,
USA, 2000.
[21] G.M. Sheldrick, SADBAS Version 2.03. Multi-Scan Absorption Cor-
rection Program, University of Go¨ttingen, Germany, 2001.
[22] A.J.M. Duisenberg, J. Appl. Crystallogr. 25 (1992) 92.
[23] M.R. Snow, E.R.T. Tiekink, Acta Crystallogr. B44 (1988) 676.
[24] A.L. Spek, J. Appl. Crystallogr. 21 (1988) 578.
[25] Y. Le Page, J. Appl. Crystallogr. 20 (1987) 264.
[26] Y. Le Page, J. Appl. Crystallogr. 21 (1988) 983.
[27] M.C. Burla, R. Caliandro, M. Camalli, B. Carrozzini, G.L. Cascar-
ano, L. De Caro, C. Giacovazzo, G. Polidori, R. Spagna, J. Appl.
Crystallogr. 38 (2005) 381.
[28] A.J.C. Wilson (Ed.), International Tables for Crystallography, vol. C,
Kluwer Academic Publishers, Dordrecht, The Netherlands, 1992.
[29] G.M. Sheldrick, SHELXL-97 Program for the Refinement of Crystal
Structures, University of Go¨ttingen, Germany, 1997.
[30] A. Meetsma, PLUTO Molecular Graphics Program. Version of
March 2006. University of Groningen, The Netherlands, 2006.
[31] A.L. Spek, (2006). PLATON Program for the Automated Analysis of
Molecular Geometry (A Multipurpose Crystallographic Tool), Ver-
sion of February 2006. University of Utrecht, The Netherlands. A.L.
Spek, J. Appl. Crystallogr. 36 (2003) 7.
Appendix A. Supplementary material
CCDC 628129 contains the supplementary crystallo-
graphic data for this paper. These data can be obtained free
ing.html, or from the Cambridge Crystallographic Data
[32] U. Abram, K. Ortner, R. Gust, K. Sommer, J. Chem. Soc., Dalton
Trans. (2000) 735.